Innovaderm Research Acquires Excelsus Statistics
July 5, 2022
Innovaderm Research Inc., a Montreal-based full-service CRO specializing in dermatology, has acquired Excelsus Statistics, a Montreal biostatistics and SAS programming firm. The acquisition expands Innovaderm's biometrics capacity and integrates Excelsus's statistical expertise (including adaptive trial design) into Innovaderm's broader CRO service offering.
- Buyers
- Innovaderm Research Inc.
- Targets
- Excelsus Statistics
- Industry
- Healthcare Services
- Location
- Quebec, Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
MMS Acquires Exploristics
February 20, 2025
Healthcare Services
MMS, a data-focused clinical research organization (CRO), has acquired Exploristics, a Belfast-based biostatistics and data-science firm. The deal adds Exploristics' KerusCloud study simulation platform and strengthens MMS's biometrics, statistical design, and global clinical trial capabilities.
-
Veristat Acquires Instat Clinical Research
October 19, 2023
Healthcare Services
Veristat, a full-service clinical research organization, has acquired Instat Clinical Research, a biometrics-focused CRO with teams in the United States and India. The deal expands Veristat's biometrics, data management, biostatistics, and statistical programming capabilities while adding offshore capacity to enable round-the-clock support for clinical studies.
-
Excelra Acquires BISC Global
April 19, 2023
Biotechnology
Excelra has acquired BISC Global, a consulting-led bioinformatics and data analytics services firm with offices in Europe and the US. The deal expands Excelra's AI/ML, bioinformatics and next-generation sequencing capabilities and combines complementary platforms and service offerings to accelerate drug discovery and development.
-
CenExel Acquires iResearch
May 3, 2022
Healthcare Services
CenExel, a Salt Lake City–based clinical research site network, acquired iResearch, a multi-specialty clinical research site with locations in Decatur and Savannah, Georgia. The deal strengthens CenExel's CNS (psychiatry and neurology) and dermatology trial capabilities while expanding its patient reach in the Atlanta metro and throughout Georgia.
-
Eurofins Scientific Acquires bioskin GmbH
August 4, 2021
Healthcare Services
Eurofins Scientific has completed the acquisition of bioskin GmbH, a Hamburg-based dermatology-focused CRO that provides clinical trials for drugs, medical devices, food supplements and advanced cosmetics. The deal expands Eurofins' clinical study management and dermatology capabilities in Germany and strengthens its Cosmetics & Personal Care testing offering.
-
Nexelis to Acquire ImmunXperts
April 4, 2020
Healthcare Services
Nexelis, a portfolio company of Ampersand Capital Partners, has signed a definitive agreement to acquire ImmunXperts, a specialty immunogenicity and immuno‑oncology testing laboratory based in Gosselies, Belgium. The add-on deal will expand Nexelis' assay development and immunology testing capabilities and is expected to close by the end of March 2020.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.